671.5500 -26.25 (-3.76%)
NSE Aug 06, 2025 15:31 PM
Volume: 1.2M
 

671.55
-3.76%
GEPL Capital
Syngene International ltd. (SIL) Limited is one of India's leading contract research company. SIL is founded in 1993 and a subsidiary of Biocon Ltd. Syngene is a leading custom research and manufacturing organization, which supports R&D; programs from lead generation to clinical supplies. The company's multi-disciplinary skills in integrated drug discovery and development include capabilities in medicinal chemistry, biology, toxicology, custom synthesis, process R&D;, cGMP manufacturing, formulation and analytical development. The company provides significant cost advantage to companies seeking to minimize their R&D; spends. The lower cost structure in Asia Pacific region helps in reducing R&D; spend by...
Syngene Internationa.. has an average target of 1030.00 from 1 broker.
More from Syngene International Ltd.
Recommended